Gitanjali Jain joins Kezar with over 15 years of experience in the healthcare industry. She most recently served as Managing Director at Solebury Trout where she advised small and mid-cap biopharmaceutical companies on investor relations strategies, messaging/communications, and capital market transactions. Ms. Jain previously served as a research associate at Medarex and StemCells, Inc. where she worked on the development of neural markers as they related to monoclonal antibody and protein fragments. She also co-authored a publication in the Journal of Neuroscience Research while in that role.

Ms. Jain holds a B.A. in Economics from Brown University and a M.A. in Biology from New York University. She also holds Series 7, 79 and 63 securities licenses.